Earlier studies reported that a high titer of PLA2R antibodies (PLA2R Ab) is associated with a poor prognosis of remission, high proteinuria production, and a high possibility of progression into end-stage renal disease [186,187,188,189]. Here, PLA2R1 is linked to stage 5 chronic kidney disease.